Atlas Trials

An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

Clinical trial NCT06874114 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06874114
Sponsor
Bayer
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Metastatic Hormone-sensitive Prostate Cancer
Start date
2025-02-28
Primary completion
2026-12-31
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.